PepJunkie Home of the Peptonauts
More

Research

Follistatin-315 (FST-315) — living evidence map

The Atlas page holds the claims; this is how its evidence evolved.

Summary

Follistatin is a monomeric glycoprotein that binds and neutralizes activin; FS315, its full-length isoform, carries an acidic C-terminal tail that the shorter FS288 lacks, the two arising from alternatively spliced messenger RNAs. · pmid:15472207

An FS315-specific immunoassay showed FS315 to be the main follistatin isoform circulating in human serum, while it was undetectable in ovarian follicular fluid. · pmid:15472207

Mechanism

Recombinant human FS315 suppressed FSH release from rat pituitary cells about as potently as native follistatin, whereas recombinant FS288 was 8 to 10 times more potent. · pmid:1906804

Identity

No public registry record is shown for this page: PubChem gave no record that proves it is this substance.


Where the evidence actually sits

Emerging50%
Preclinical only50%

Proportion of the 2 claims about Follistatin-315 (FST-315) standing at each tier. Community volume is shown on the Consensus tab beside this and is never averaged into it.


Living evidence history

Recombinant expression of human follistatin with 315 and 288 amino acids: chemical and biological comparison with native porcine follistatin. (1991) · preclinicalDifferential distribution of follistatin isoforms: application of a new FS315-specific immunoassay. (2004) · emerging19912004

2 resolved citations, oldest to newest, coloured by tier. Retractions and contradictions land here as they are recorded.


Structure

No structure representation on record. PepJunkie draws only what an authoritative record supplies; for a peptide that is the residue sequence, and none has been curated for Follistatin-315 (FST-315) yet.


Dose evidence, rung by rung

No established safe human dose. Nothing on file establishes one. That is a statement about the evidence PepJunkie holds, not a promise about the molecule.

  1. Approved-label dose · a resolved regulatory document names a labelled dose

    nothing resolved on this rung

  2. Studied human doses · resolved human studies at the established tier

    nothing resolved on this rung

  3. Observational evidence · resolved human data at the emerging tier: thin, or contested
    • Differential distribution of follistatin isoforms: application of a new FS315-specific immunoassay. · pmid 15472207 · 2004
  4. Community-reported protocols · protocol propositions from distinct members, counted once per human

    nothing resolved on this rung

  5. Preclinical evidence · resolved animal, cell or mechanistic work
    • Recombinant expression of human follistatin with 315 and 288 amino acids: chemical and biological comparison with native porcine follistatin. · pmid 1906804 · 1991

2 resolved citations, 0 unresolved (an unresolved citation lends nothing). Community volume is its own rung and is never averaged into the evidence rungs.